HTF Market
Intelligence released a new research report of 25 pages on title 'Voyager
Therapeutics Inc (VYGR) - Financial and Strategic SWOT Analysis Review' with detailed analysis, forecast and
strategies.
Summary
Voyager Therapeutics Inc (Voyager) is a gene therapy
company that develops treatments for fatal and debilitating diseases of the
central nervous system. The company provides treatment for adeno-associated
virus gene therapy field by selecting, designing and manufacturing vectors. Its
product includes VY-AADC01, which is under Phase 1b study, is used for treating
Parkinson’s disease. Voyager’s pipeline also comprise preclinical programs for
amyotrophic lateral sclerosis, Friedreich’s ataxia, Huntington's disease and
spinal muscular atrophy. The company offers development services in the areas
such as vector optimization and engineering, dosing techniques, and process
development and production. Voyager is headquartered in Cambridge,
Massachusetts, the US.
Voyager Therapeutics Inc Key Recent Developments
May 09,2017: Voyager Therapeutics Reports First Quarter
2017 Financial Results and Corporate Highlights
Mar 15,2017: Voyager Therapeutics Reports Fourth Quarter
and Full Year 2016 Financial Results and Corporate Highlights
Jan 05,2017: Voyager Therapeutics Elects Wendy Dixon,
Ph.D. and Glenn Pierce, M.D., Ph.D. to Board of Directors
Jan 03,2017: Voyager Therapeutics Appoints Jane Pritchett
Henderson as Chief Financial Officer
Nov 10,2016: Voyager Therapeutics Provides Third Quarter
2016 Investor Update
This comprehensive SWOT profile of Voyager Therapeutics
Inc provides you an in-depth strategic analysis of the company’s businesses and
operations. The profile has been compiled by GlobalData to bring to you a clear
and an unbiased view of the company’s key strengths and weaknesses and the
potential opportunities and threats. The profile helps you formulate strategies
that augment your business by enabling you to understand your partners,
customers and competitors better.
This company report forms part of GlobalData’s ‘Profile
on Demand’ service, covering over 50,000 of the world’s leading companies. Once
purchased, GlobalData’s highly qualified team of company analysts will
comprehensively research and author a full financial and strategic analysis of
Voyager Therapeutics Inc including a detailed SWOT analysis, and deliver this
direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information
including*,
- Business description – A detailed description of the
company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the
company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s
strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated
with the company.
- Major products and services – A list of major products,
services and brands of the company.
- Key competitors – A list of key competitors to the
company.
- Key employees – A list of the key executives of the
company.
- Executive biographies – A brief summary of the
executives’ employment history.
- Key operational heads – A list of personnel heading key
departments/functions.
- Important locations and subsidiaries – A list and
contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key
manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The
latest financial ratios derived from the annual financial statements published
by the company with 5 years history.
- Interim ratios for the last five interim periods – The
latest financial ratios derived from the quarterly/semi-annual financial
statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is
unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its
operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure,
operations, major products and services, prospects, locations and subsidiaries,
key executives and their biographies and key competitors.
Understand and respond to your competitors’ business
structure and strategies, and capitalize on their weaknesses. Stay up to date
on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas
of development or decline are analyzed and presented in the profile
objectively. Recent developments in the company covered in the profile help you
track important events.
Equip yourself with information that enables you to
sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit
are sized up and its growth potential assessed in the profile. Competitive
and/or technological threats are highlighted.
Scout for potential investments and acquisition targets,
with detailed insight into the companies’ strategic, financial and operational
performance.
- Financial ratio presented for major public companies in
the profile include the revenue trends, profitability, growth, margins and
returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or
business research.
- Key elements such as SWOT analysis, corporate strategy
and financial ratios and charts are incorporated in the profile to assist your
academic or business research needs.
Make an enquiry
before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/407862-voyager-therapeutics-inc-4
Table of Contents
Section 1 - About
the Company
Voyager
Therapeutics Inc - Key Information
Voyager
Therapeutics Inc - Overview
Voyager
Therapeutics Inc - Key Employees
Voyager
Therapeutics Inc - Key Employee Biographies
Voyager
Therapeutics Inc - Key Operational Heads
Voyager
Therapeutics Inc - Major Products and Services
Voyager
Therapeutics Inc - History
Voyager
Therapeutics Inc - Company Statement
Voyager
Therapeutics Inc - Locations And Subsidiaries
Voyager
Therapeutics Inc - Key Manufacturing facilities
Head Office
Other Locations
& Subsidiaries
Section 2 -
Company Analysis
Voyager
Therapeutics Inc - Business Description
Voyager Therapeutics
Inc - Corporate Strategy
Voyager
Therapeutics Inc - SWOT Analysis
SWOT Analysis -
Overview
Voyager
Therapeutics Inc - Strengths
Voyager
Therapeutics Inc - Weaknesses
Voyager
Therapeutics Inc - Opportunities
Voyager
Therapeutics Inc - Threats
Voyager
Therapeutics Inc - Key Competitors
Section 3 -
Company Financial Performance Charts
Voyager
Therapeutics Inc - Financial Ratios
Financial Ratios -
Capital Market Ratios
Financial Ratios -
Annual Ratios
Financial Ratios -
Interim Ratios
Financial Ratios -
Ratio Charts
Section 4 -
Appendix
Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Note*: Some
sections may be missing if data is unavailable for the company List of Tables
Voyager
Therapeutics Inc, Key Information
Voyager
Therapeutics Inc, Key Ratios
Voyager
Therapeutics Inc, Share Data
Voyager
Therapeutics Inc, Major Products and Services
Voyager
Therapeutics Inc, History
Voyager
Therapeutics Inc, Key Employees
Voyager
Therapeutics Inc, Key Employee Biographies
Voyager
Therapeutics Inc, Key Operational Heads
Voyager
Therapeutics Inc, Other Locations
Voyager
Therapeutics Inc, Subsidiaries
Voyager
Therapeutics Inc, Key Manufacturing facilities
Voyager Therapeutics
Inc, Key Competitors
Voyager
Therapeutics Inc, SWOT Analysis
Voyager
Therapeutics Inc, Ratios based on current share price
Voyager
Therapeutics Inc, Annual Ratios
Voyager
Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market
Ratios
Equity Ratios
Profitability
Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Voyager
Therapeutics Inc, Performance Chart
Voyager
Therapeutics Inc, Ratio Charts
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=407862
Contact Us:
CRAIG FRANCIS (PR
& Marketing Manager)
sales@htfmarketreport.com
Ph: +1 (206) 317
1218
No comments:
Post a Comment